India’s device market has no intelligence layer of its own.
India is among the world’s fastest-growing medical-device markets and remains substantially import-dependent. CDSCO licensing is divided between central and state authorities under a still-maturing device-rules regime, and the intelligence tools that exist are built for US and EU pharma — they do not structure India’s domestic device base. Hospitals, manufacturers and regulators decide on scattered, single-jurisdiction data.
India in depth, the world alongside.
Reconciled across seven regulators — CDSCO, FDA, EUDAMED, Health Canada, TGA, PMDA and MHRA. The figures below are current-build counts, refreshed as new data lands.
The CDSCO base, connected to each maker’s global footprint.
5,195 manufacturers and importers and 161,000 device licences across 29 states and risk classes A–D — each with intended-use detail, and each linked to the same company’s FDA clearances and global safety record. The domestic base no global tool covers.
India manufacturers
Every CDSCO-registered maker and importer — licences, risk classes, states, intended use — linked to its global footprint.
View →Device families
Cross-regulator profiles per device class: regulatory pathway, adverse-event signals, and the manufacturer landscape.
View →Hospital setup
Tier-appropriate device and consumable kits with INR costing, for Indian hospital procurement.
View →One profile, every regulator.
The connection is the product: the same device or maker, reconciled across jurisdictions, with the safety and regulatory record attached.
Cross-regulator profiles
A device or manufacturer reconciled across CDSCO, FDA, EUDAMED, Health Canada and TGA — joined at the entity level, not chased across portals.
Adverse-event signals
MAUDE reports surfaced with disproportionality scoring (PRR), severity and date-of-event, per device family and per manufacturer.
Recall tracking
FDA and Health Canada recalls joined to the record, with class, reason and status. EU FSCAs added as published.
Manufacturer-canonical
One company, many name variants, resolved to a single identifier — so India and global records line up rather than fragmenting on spelling.
Free for those who learn and research; built for those who buy and oversee.
Safety and reference data are open to the people incumbents price out — researchers, students and clinicians. The synthesis, cross-rail and procurement depth is what institutions pay for.
Hospitals & procurement
Device choice, equivalents, recall history, manufacturer reliability, and tier-appropriate kits with INR costing.
Device manufacturers
Competitive and regulatory comparison — who is licensed in which classes, set against the global record.
Government & regulators
Tender intelligence across facility tiers; cross-regulator vigilance signals and recall chronologies.
MNCs
India coverage existing tools lack, cross-linked to a global portfolio for market access and competitive intelligence.
Researchers & academics
Structured, cited, cross-regulator device data with transparent sourcing — and, in time, cross-rail links to drugs and biologics.
Medical & biomedical students
A free, sourced device reference for training — India's next clinicians, engineers and procurement leads.
Clinicians & the public
Device safety, recall and regulatory status — open and free, on every profile.
Every claim carries its source.
Data is presented at an explicit trust tier and refreshed on a stated cadence. Expert clinical verification is the funded next step; until a field is reviewed, it is marked as registry or AI-reviewed, not verified.
Read the methodology →Sourcing per field
Each fact carries its source and retrieval date. No claim is unsourced.
Trust tiers
Registry-only and AI-reviewed (cross-checked) are live today; expert review (clinical sign-off) is rolling out as the review board is onboarded.
Safety stays free
Recall and adverse-event data are public on every profile, refreshed on a short cycle.
Refresh cadence
Safety-critical fields refresh on a 60-day cycle; regulatory and classification on 180. Last refresh shown on each page.